Brian S. Kim, MD, MTR, FAAD
Physician-Scientist | Neuroimmunologist | Dermatologist | Inventor | Entrepreneur | firstname.lastname@example.org
Dr. Kim received his M.D. from the University of Washington, was a HHMI-NIH Scholar, completed residency in dermatology at the University of Pennsylvania where he earned a Master of Translational Research (MTR). The Kim Lab focuses on mechanisms that underlie skin inflammation and the sensation of itch as a fundamental, broad, model paradigm of neuroimmunology. Key discoveries include the first identification of group 2 innate lymphoid cells (ILC2s) in the skin of both mice and humans, novel contributions of basophils, ILC2s, and natural killer (NK) cells to skin inflammation, and unveiling how immune cells and type 2 cytokines/JAK signaling directly influence sensory neuronal responses. He has >120 peer-reviewed publications, multiple NIH grants, designed pivotal clinical trials that led to novel FDA-approved treatments, and is an inventor of itch-centered technologies. His research has led to awards and funding from NIH, Doris Duke Charitable Foundation, American Skin Association, American Academy of Dermatology, American Society for Clinical Investigation, American Dermatological Association, and International League of Dermatological Societies. He holds a patent for the use of JAK inhibitors for chronic itch. He is on the scientific advisory board for Abrax Japan, Granular Therapeutics, Recens Medical, National Eczema Association, and Cell Reports Medicine. He is on the editorial board of Journal of Allergy and Clinical Immunology, section editor for Journal of Immunology and on the board of reviewing editors for eLife.
Kelsey received her B.S. in Materials Science and Engineering at the Massachusetts Institute of Technology (M.I.T.). She is an M.D. candidate at the Icahn School of Medicine at Mount Sinai.
Dr. Tamari is a pediatric allergy and immunology specialist from Jikei University in Tokyo, Japan. He is studying how cytokines regulate neuronal responses in the skin and lung.
Karen G. Anthony, PhD
Karen obtained her PhD in Microbiology and Molecular Biology at the University of Alberta, Edmonton, Canada. Karen has extensive drug discovery experience in the biotech industry. She currently serves as the Director of Sponsored Research Program in Dr. Kim’s lab.
Rintaro Shibuya, MD, PhD
Dr. Shibuya received both his MD and PhD degrees at Kyoto where he worked with Dr. Kenji Kabashima. There, he worked as a dermatologist and studied skin immunology. His current interests involve studying interorgan communication between the skin and the lung focusing on neuro-immune axis.
Hisato Iriki, MD, PhD
Dr. Iriki received his medical degree from Keio University School of Medicine (Japan) in 2011. There, he went on to complete his junior residency training. While Dr. Iriki was training for his dermatology residency, he also earned his PhD.
Zhen Wang, MD, PhD
Received MD/PhD from the University of Iowa and is currently studying neuroimmunologic mechanisms that underlie atopic disease.
Instructor of Medicine in the Division of Allergy and Immunology.
Dr. Yang received her MD/PhD from the University of Pennsylvania School of Medicine and is Instructor of Medicine in the Division of Dermatology. She is currently understanding the developmental pathways that regulate innate immune responses in skin inflammation.
Dr. Wang is an attending physician at First Affiliated Hospital of Sun Yat-sen University in Guangdong, China. She is currently pursuing her PhD degree and studying innate immune mechanisms that underlie atopic dermatitis in both mice and humans.
Anna is a M.D./Ph.D. student in the MSTP program pursuing a Ph.D. in immunology. She is interested in understanding how the early mechanisms that drive itch in the setting of atopic dermatitis.